Landscapes / Companies
Innate Pharma not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials · 6 in all
Trials
2 active
9 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
IPH5201not checked |
— |
Phase 2 | Jun 2027Phase 2 trial completes | ||
| Next date | Jun 2027 · Phase 2 trial completes | ||||
| Also tested for | Non Small Cell Lung Cancer | ||||
| Open drug page | |||||
— |
Phase 1 | Apr 2028Phase 1 trial completes | |||
| Next date | Apr 2028 · Phase 1 trial completes | ||||
| Also tested for | Advanced or Metastatic Solid Tumors | ||||
| Open drug page | |||||
About
- No active trial
- IPH2101, IPH6501, lacutamab, Monalizumab
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021